Venezuela Healthcare, Regulatory and Reimbursement Landscape – CountryFocus

GlobalData, the industry analysis specialist, has released its latest report, “Venezuela Healthcare, Regulatory and Reimbursement Landscape – CountryFocus”. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Venezuela. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

The Venezuelan pharmaceutical market used to be one of the most lucrative markets in the world. However, its growth has been severely impeded since 2018 as a result of the political and socioeconomic crisis. Hyperinflation, breakdown of the health system, and inefficient patent laws have negatively impacted the pharmaceutical market. The pharmaceutical market grew from $6.2B in 2010 to $22.3B in 2016 at a Compound Annual Growth Rate (CAGR) of 23.7%. The Venezuelan Over-the-counter (OTC) drugs market decreased from $371.1M in 2013 to $286.9M in 2019 at a negative CAGR of 4.2%. It is expected to further decrease to $255.8M in 2023 at a negative CAGR of 2.3% from 2020.


The report provides information on the healthcare, regulatory, and reimbursement landscape in Venezuela, and includes:

An overview of the pharmaceutical market, comprising market size, segmentation, and key drivers and barriers

Profiles and SWOT analyses of the major players in the pharmaceutical market: Bayer, Boehringer Ingelheim, GlaxoSmithKline, Novartis, and Pfizer

Profiles and SWOT analyses of the major players in the medical device market: Medtronic and Roche Diagnostics

An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in healthcare market, HealthTech landscape, reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices

Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure

An overview of the opportunities for and challenges to growth in the Venezuelan healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to:

Develop business strategies by understanding the trends shaping and driving Venezuela’s healthcare market

Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Venezuela’s healthcare market in the future

Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance

Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership

Table of Contents

1 Table of Contents

1.1 List of Figures

1.2 List of Tables

2 Executive Summary

2.1 Executive Summary

2.2 Key Highlights

2.3 Key Events: Venezuelan Pharmaceutical News, 2014-2019

2.4 Key Events: Venezuelan Pharmaceutical Market

2.5 Political and Economic Scenario – Venezuela

2.6 Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2019-2020

2.7 Key Events: Mergers and Acquisitions

2.8 Country Profile, Venezuela, 2019

3 Overview of Pharmaceutical Market

3.1 Pharmaceutical Market – Overview

3.2 Key Factors affecting the Venezuelan Healthcare System

3.3 Pharmaceutical Market – Exports

3.4 Pharmaceutical Market – Imports

3.5 Pharmaceutical Supply, Venezuela

3.5 Pharmaceutical Market – Market Segments

3.6 Pharmaceutical Market – Market Segment: Over-the-Counter Drugs, Venezuela

3.7 COVID-19 Epidemiology, Venezuela

3.8 Government Response to Mitigate COVID-19

3.9 COVID-19 Impact and Developments in Healthcare Market, South and Central America

3.10 Pharmaceutical Market – Major Players

4 Overview of Medical Devices Market

4.1 Medical Device Market – Overview

4.2 Medical Device Market – Major Players

5 Pharmaceutical and Medical Device Market – Drivers and Barriers

5.1 Drivers

5.2 Barriers

6 Deal Analysis

6.1 Deal Analysis: M&A, VF and PE Deals, Pharmaceutical Market, Venezuela 2019-2020

7 HealthTech Landscape

7.1 HealthTech Landscape, Venezuela

7.2 Digital Health Venezuela

7.3 Key HealthTech Deals, Venezuela

7.4 Digital Health Regulations

7.5 HealthTech Landscape- Venezuela- Benefits and Risks

8 Market Access

8.1 Overview of Healthcare System, Venezuela

8.2 Reimbursement Process, Venezuela

8.3 Overview of Health Insurance, Venezuela

8.4 Healthcare Spending and Health Price Index, Venezuela

8.5 Pricing Policies, Venezuela

8.6 Regulatory Landscape, Venezuela

8.6.1 Market Authorization for Pharmaceutical Drugs, Venezuela

8.6.2 Market Authorization for Biosimilars, Venezuela

8.6.3 Market Authorization for Medical Devices, Venezuela

8.6.4 Licensing Process for Pharmaceutical Exports and Imports

8.6.5 Intellectual Property Rights, Patent, Venezuela

8.6.6 Intellectual Property Rights, Trademark, Venezuela

8.6.7 Clinical Trial Regulations, Venezuela

8.6.8 Pharmaceutical Clinical Trials Landscape, Venezuela

8.6.9 Pharmaceutical Advertising Regulations, Venezuela

8.6.10 Labeling and Packaging Regulations, Venezuela

9 Country Healthcare Landscape

9.1 Healthcare Programs, Venezuela

9.2 Healthcare Facilities, Venezuela

9.3 Life Expectancy and Immunization Rate, Venezuela

9.4 Environmental Health, Venezuela

9.5 Disease Burden, Venezuela

9.6 Healthcare Expenditure

10 Trade Associations, Venezuela

11 Opportunities and Challenges

12 Appendix

12.1 Research Methodology

12.1.1 Coverage

12.1.2 Secondary Research

12.1.3 Forecasts

12.1.4 Expert Panel

12.2 Bibliography

12.3 Contact Us

12.4 Disclaimer

List of Tables

Table 1: COVID-19 Indicators (Number of cases), Global and Venezuela, 2020

Table 2: COVID-19 Protection Plan, Venezuela, 2020

Table 3: COVID-19 Diagnostic Test Kits, Venezuela, 2020

Table 4: Import Tariffs, Venezuela, 2019

Table 5: Old Age, Disability, and Survivors Source of Funds, Venezuela, 2019

Table 6: Biosimilar Regulatory Pathway Comparison with WHO Standards, Venezuela, 2019

List of Figures

Figure 1: Pharmaceutical Market, Venezuela, Revenue ($B), 2010-2016

Figure 2: OTC Drugs Market, Venezuela, Revenue ($M), 2013-2019

Figure 3: Economic Sanctions, Venezuela, 2020

Figure 4: Country Profile, Venezuela, 2019

Figure 5: Pharmaceutical Market, Venezuela, Revenue ($B), 2010-2016

Figure 6: Pharmaceutical Market, Venezuela, Production Volume (million units), 2010-2016

Figure 7: Pharmaceutical Exports ($M), Venezuela, 2010-2019

Figure 8: Top Export Partners, Venezuela, 2013

Figure 9: Pharmaceutical Imports ($B), Venezuela, 2010-2019

Figure 10: Top Import Partners, Venezuela, 2013

Figure 11: OTC Drugs Market, Major Categories ($M), Venezuela, 2019

Figure 12: OTC Drugs Market, Revenue ($M), Venezuela, 2013-2019

Figure 13: OTC Drugs Market, Major Distribution Channels ($M), Venezuela, 2017

Figure 14: COVID-19 (Number of cases), Venezuela, 2020

Figure 15: COVID-19 (Number of deaths), Venezuela, 2020

Figure 16: COVID-19 Government Actions, Venezuela, 2020

Figure 17: COVID-19 Clinical Trials Count By Trial Status, South and Central America, 2020

Figure 18: COVID-19 Clinical Trials Count By Trial Phase, South and Central America, 2020

Figure 19: Top Five COVID-19 Clinical Trials Sponsors By Count, Venezuela, 2020

Figure 20: Pharmaceutical Market, Major Players, 2019

Figure 21: Deal Value and Deal Count, Pharmaceutical Market, Venezuela, 2019-2020

Figure 22: Deal Value and Deal Count, Quarterly, Pharmaceutical Market, Venezuela, 2019-2020

Figure 23: Deal Count by Therapy Area, Pharmaceutical Market, Venezuela, 2019-2020

Figure 24: Deal Value ($M), HealthTech, Venezuela, 2017-2020

Figure 25: Deal Count, HealthTech, Venezuela, 2017-2020

Figure 26: Digital Health Startups, Venezuela, 2019

Figure 27: Overview of Healthcare System, Venezuela, 2017

Figure 28: Reimbursement Process, Venezuela, 2018

Figure 29: Direct Premiums ($B), Venezuela, 2011-2018

Figure 30: Major Health Insurance Companies (% market), Venezuela, 2018

Figure 31: Out-of-Pocket Expenditure (% of current health expenditure), Venezuela, 2010-2017

Figure 32: Health CPI (% change), Venezuela, 2010-2019

Figure 33: Instituto Nacional de Higiene Rafael Rangel, Organization Chart, 2020

Figure 34: Drug Approval Process, Venezuela, 2019

Figure 35: Certificate Types, Venezuela, 2019

Figure 36: Patent Application Process, Venezuela, 2019

Figure 37: Trademark Approval Process, Venezuela, 2020

Figure 38: Clinical Trial Approval Process, Venezuela, 2020

Figure 39: Pharmaceutical Clinical Trials Count by Trial Status, Venezuela, 2018-2020

Figure 40: Pharmaceutical Clinical Trials Count by Phase, Venezuela, 2018-2020

Figure 41: Pharmaceutical Clinical Trials Count by Therapy Area, Venezuela, 2018-2020

Figure 42: Top Five Pharmaceutical Clinical Trials Sponsors by Count, Venezuela, 2018-2020

Figure 43: Labeling Information, Venezuela, 2018

Figure 44: Barrio Adentro Major Milestones, Venezuela, 2003-2017

Figure 45: Hospital Beds (per 1,000 population), Venezuela, 2011-2018

Figure 46: Health Infrastructure Status (%), Venezuela, 2018

Figure 47: Life Expectancy (in years), Venezuela, 2012-2019

Figure 48: Immunization Rate (%), Venezuela, 2010-2018

Figure 49: PM2.5 (µg per m3), Venezuela, 2010-2017

Figure 50: CO2 Emissions (metric tons), Venezuela, 2010-2018

Figure 51: Major Causes of Mortality (persons), Venezuela, 2016

Figure 52: Major Causes of Male Mortality (persons), Venezuela, 2016

Figure 53: Major Causes of Female Mortality (persons), Venezuela, 2016

Figure 54: Disability-Adjusted Life Years by Major Disease (‘000), Venezuela, 2016

Figure 55: Healthcare Expenditure as a Percentage of GDP (%), Venezuela, 2010-2018

Figure 56: Public-Private Health Expenditure (% of total health expenditure), Venezuela, 2010-2018

Figure 57: Opportunities and Challenges


Discounts available for multiple report purchases.
+44 (0) 161 359 5813

Join our mailing list

Saved reports